New Delhi:- There are many diseases around the world which are incurable or new methods of treatment are being discovered. Cancer is the biggest disease and it is difficult to get proper treatment for it. Recently, scientists of Indian Institute of Technology, Roorkee have done a new miracle. In this, Roorkee scientists have developed a next-generation antibody discovery platform that identifies the disease and searches for treatment. The newly developed platform enables rapid identification of antibodies with high stability and strong binding to infectious diseases, cancer, autoimmune disorders and emerging pathogens.
Know what is the complete research
Talking about the new innovation done by the Indian Institute of Technology, Roorkee, it is an important step towards a self-reliant India, which focuses on developing advanced diagnostic tools locally. This new research involves the development of a very large, high-diversity single-domain antibody (nanobody) library.
In infectious diseases, cancer, autoimmune disorders and emerging pathogens, this platform helps in the rapid identification of highly stable and high-affinity antibodies (which bind very strongly to the target, making them more accurate and effective). By significantly reducing the time to discovery, this discovery fills a major gap in the healthcare response. These prove to be especially helpful in emergency situations.
What did the professor say on this research?
Giving information about the efforts made towards the treatment of cancer, Professor of Biosciences and Bioengineering Department of IIT Roorkee. Rajesh Kumar said, “By developing a universal, high-diversity antibody discovery system in India, we are strengthening our capabilities to respond rapidly to diseases and making affordable diagnostics and treatments available to those who need them most.” This type of research works to fulfill the vision of self-reliant India and Make in India. This is especially important for low- and middle-income countries, where access to timely and affordable healthcare solutions remains a challenge.
Apart from this, Director of IIT Roorkee, Prof. Of. Of. Pant said, “This development shows how basic research, translational intent and industry collaboration can solve the pressing challenges of society.” The institute said it has signed a Memorandum of Understanding (MoU) with IMGenex India to promote collaborative research, co-development of advanced biologics and capacity building in areas such as antibody engineering, diagnostics, therapeutics and bioprocess development.
Will prepare for the pandemic
This initiative is an indigenous research initiative to strengthen capabilities, create intellectual property and reduce dependence on imported biologics. It complements national efforts to promote translational research (applying scientific findings from the laboratory directly to the treatment of patients), prepare for pandemics, and strengthen health services for the long term.
Post Views: 225
Comments are closed.